孤立性生物瓣与机械瓣主动脉瓣置换术后长期生存相似:倾向匹配分析
该研究基于1990至2020年Cleveland Clinic的6143例孤立性主动脉瓣置换患者,通过倾向匹配比较生物瓣与机械瓣的围术期结局,并用随机森林分析全队列生存。匹配后院内并发症与死亡率相似,生物瓣组住院更短但再手术率更高;18年生存率生物瓣60%对机械瓣58%,再手术未影响生存。
要点
- 匹配后生物瓣与机械瓣院内并发症及死亡率相似,生物瓣住院更短。
- 生物瓣再手术率更高(14年32%对8%),但再手术后5年生存无差异。
- 18年生存率生物瓣60%对机械瓣58%,仅再手术风险不应阻碍年轻患者选用生物瓣。
核心结论
- 生物瓣主动脉瓣置换短期结局优良,18年生存与机械瓣相似。
- 再手术未对生存产生不利影响,仅再手术风险不应阻碍年轻患者使用生物瓣。
研究设计与样本
- 回顾性队列研究,1990年1月至2020年1月Cleveland Clinic共6143例孤立性主动脉瓣置换患者。
- 637例接受机械瓣,5506例接受生物瓣;倾向匹配识别527对匹配患者比较围术期结局,并对全队列行随机森林机器学习生存分析。
主要发现
- 匹配患者中,卒中、深部胸骨伤口感染及因出血再手术等院内主要并发症相似。
- 院内死亡生物瓣组2例(0.38%)对机械瓣组3例(0.57%),P > .9。
- 生物瓣组住院中位6天,机械瓣组7天,P < .0001。
- 再手术后5年生存率85%对82%,P = .6;风险校正随机森林预测18年生存率生物瓣组60%、机械瓣组58%。
临床怎么用
- 年轻患者选择生物瓣时,可参考本研究中18年生存与机械瓣相似的结果。
- 生物瓣再手术风险较高但再手术后生存未受损,不应仅因再手术风险而排除生物瓣。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Improved durability and preference to avoid anticoagulation have led to increasing use of bioprostheses in younger patients despite the need for eventual reoperation. Therefore, we compared in-hospital complications, reoperation, and survival after bioprosthetic and mechanical aortic valve replacement. METHODS: From January 1990 to January 2020, 6143 patients underwent isolated aortic valve replacement at Cleveland Clinic; 637 patients received a mechanical prosthesis and 5506 a bioprosthesis. Propensity matching identified 527 well-matched pairs (83% of possible matches) for comparison of perioperative outcomes. The average age of patients was 54 years in the bioprosthesis group and 55 years in the mechanical prosthesis group. Random Forest machine-learning analysis was performed to compare survival using the entire cohort of 6143 patients. RESULTS: Among matched patients, major in-hospital complications, including stroke, deep sternal wound infection, and reoperation for bleeding, were similar, as was in-hospital mortality (2 in the bioprosthesis group [0.38%] vs 3 in the mechanical prosthesis group [0.57%]; P > .9). Patients receiving a bioprosthesis had shorter hospital stays (median 6 vs 7 days, P < .0001). Fifty-one patients (32% at 14 years) in the bioprosthesis group and 17 patients in the mechanical prosthesis group (8% at 14 years) underwent reoperation (P [log-rank] < .0001); 5-year survival after reoperation was 85% versus 82% (P = .6). Risk-adjusted Random Forest prediction of 18-year survival was 60% in the bioprosthetic group and 58% in the mechanical prosthesis group. CONCLUSIONS: Aortic valve bioprostheses are associated with excellent short-term outcomes and 18-year survival similar to that of patients receiving mechanical valves. Reoperation does not adversely affect survival. These results suggest that risk for reoperation alone should not deter the use of bioprostheses in younger patients.
引用
- Attia T, Yang Y, Svensson LG, et al. Similar long-term survival after isolated bioprosthetic versus mechanical aortic valve replacement: A propensity-matched analysis. J Thorac Cardiovasc Surg. 2021. PMID: 33892946. doi:10.1016/j.jtcvs.2020.11.181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。